Alexa

10 Fastest Growing Healthcare Companies 2019

Tailored Made Solutions as Per Each Cancer Patient Requirement - Onkos Surgical

thesiliconreview-patrick-treacy-ceo-onkos-surgical-19

Based in Parsippany N.J., Onkos Surgical is a privately held, specialityMedTech company founded in 2015. It believes that individuals with cancer requiring surgery deserve solutions designed specifically for them. This principle is the driving force behind the Precision Oncology initiatives. Built on a digital platform, the solutions are rooted in unmatched expertise in patient imaging analysis, personalized surgical planning, and the latest advancements in 3D printing. Onkos Surgical is passionate about reducing complexity for the customers and addressing the clinical challenges associated with tumour surgery.

Patrick Treacy, Antony Koblish and Adele Oliva saw a unique opportunity for one company to demonstrate leadership and set the agenda for innovation in surgical oncology. With best-in-class innovation partners, Onkos Surgical will deliver high-quality implants and instruments that meet the unique needs of musculoskeletal tumour patients. From modular segmental systems to customized solutions and patient-specific products, Onkos Surgical will partner with surgeons to provide new innovations to help address complex cases.

Onkos Surgical has capabilities to increase the speed and delivery of innovation. The company is leveraging new technologies, such as 3D printing, to meet the unique needs of the cancer patient or surgeon. It develops products for both hard and soft-tissue applications while continuing to explore strategic partnerships to differentiate the firm’s product portfolio. With great customer responsiveness, manufacturing lead-times and quality, its vision is to be able to service and support the needs of the surgical oncologist

The company believes that Individuals with cancer requiring surgery deserve solutions designed specifically for them. These individuals, their caregivers and their support network deserve an organization passionately championing their cause. It exists to maintain a singular focus on surgical oncology by looking at everything it does through the lens of the cancer surgeon and their patients.

Onkos Surgical is said to do the following:

  • Find solutions to its patients’ unmet clinical needs and advocate for their cause.
  • Partner with surgical oncologists through research, education and innovation, to treat their patients more effectively and more efficiently.
  • Collaborate with regulatory agencies to find pathways to provide timely solutions while upholding the highest standards of quality or compliance.
  • Fulfil the employees’ desire to make a difference in the lives of the patients they serve while achieving their own professional growth.
  • Deliver value to the customers and shareholders.

Products Offered by the Company

uDesign Patient Solutions:uDesign Patient Solutions is a consultative, concierge level service provided by ONKOS SURGICAL. uDesign brings the level of expertise and surgical planning you demand in complex cases to each and every one of your cases. The interactive experience enables a personalized planning approach for each patient allowing you to better manage your outcomes.

ELEOS™ Limb Salvage System: ONKOS SURGICAL has a singular commitment to advancing innovation that will dramatically impact the lives of your patients. Introducing ELEOSTM, the modular limb salvage system that is indicated for procedures where radical resection and replacement of the distal femur, proximal femur, proximal tibia or total femur is required. The design combines OPERATIVE SIMPLICITY with a PROVEN DESIGN in one comprehensive, interchangeable system.

MyTray™: Current work-flow in tumour and complex revision cases can be challenging due to the number of required instrument trays. With uDesign, ONKOS’ advanced surgical planning capabilities allow for a streamlined procedural approach, delivered in the convenience of personalized instrument trays called MyTray.

GenVie™: it brings focus and innovation to the musculoskeletal oncology. GenVieTMRegenerative Biologics includes a suite of biologic products with applications specific to musculoskeletal oncology and healing.

My3D™: Every tumour, fracture, and complex revision case is different. Using My3DTM technology, ONKOS SURGICAL develops personalized implant, instrument and anatomic model designs to aid surgeons when performing operative procedures. Highly qualified image processors segment CT scans to create 3D computer models of the hard and soft (tumour) tissue. The models are then reviewed by the surgeon in partnership with technical experts to generate essential pre-operative and intra-operative surgical solutions, allowing the surgeon to better manage individual patient outcomes.

The Mastermind of the Company

Patrick Treacy | Co-Founder, President and CEO

Patrick is passionate about leading a team and organization dedicated to supporting healthcare professionals in the area of surgical oncology. Prior to Onkos Surgical, Patrick was Executive Vice President of PDI and President of PDI Healthcare where he was responsible for oversight of strategic initiatives as well as the financial performance of the Healthcare Division.

Prior to joining PDI, Patrick developed a passion for the advancement of surgical oncology in multiple roles in R&D, Marketing and General Management with Howmedica (a division of Pfizer) and Stryker. In his early days at Howmedica, Patrick was responsible for the development of and launch of the company’s first FDA cleared product offering in orthopaedic oncology. Patrick also holds implant and instrument design patents in orthopaedic surgery.

“We at ONKOS Surgical have a single commitment and that is tocreate advance innovation that will dramatically impact the lives of your patients.”